Skip to content

Analysis of Etiology, Drug Resistance and Direct Economic Burden of Surgical Site Infection in Orthopedic Surgery

Analysis of Etiology, Drug Resistance and Direct Economic Burden of Surgical Site Infection in Orthopedic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127692
Enrollment
Unknown
Registered
2026-07-06
Start date
2026-07-06
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical site infection

Interventions

Orthopedic SSI Infection Group:None
Control group:None
Case group:None

Sponsors

Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Part 1: Patients who developed surgical site infection (SSI) following orthopedic surgery at our hospital between January 1, 2019 and December 31, 2025. SSI diagnosis conformed to the CDC/NHSN criteria of the United States. Part 2: All patients receiving orthopedic surgery during the identical study period. The infection group included patients complicated with postoperative SSI; The control group comprised patients who underwent the same type of surgery in the same department over the same period without SSI.

Exclusion criteria

Exclusion criteria: Part 1: Patients with pre-existing infection before surgery, those who died within 48 hours after operation, and patients with non-surgical site infections. Part 2: Patients with missing hospitalization cost data and those with a length of hospital stay less than 1 day.

Design outcomes

Primary

MeasureTime frame
Pathogen species and antimicrobial resistance rate;Hospitalization cost;Length of hospital stay;

Secondary

MeasureTime frame
Cost composition;

Countries

China

Contacts

Public ContactYanQi Jin

Affiliated hangzhou first people's hospital, zhejiang university school of medicine

jinyanqi1996@163.com+86 571 56007506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026